Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.4.2 is shown, and the prior Revision: v3.4.1 notice is removed. The changes appear to be site-wide UI/notice updates rather than updates to the study details.SummaryDifference0.3%

- Check14 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedGlossary visibility was added to the study page. Wording and capitalization for QC criteria and FEAR Act data were standardized, and the revision updated to v3.4.0.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 label; this is a minor technical update with no impact on trial content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page adds a Locations section with listed sites (Massachusetts, Oregon, Texas, Victoria, Catalonia) and a revision tag v3.3.3, replacing the prior v3.3.2.SummaryDifference0.5%

- Check85 days agoChange DetectedThe page now displays Revision: v3.3.2 as the current revision, replacing Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.